Some patients also experience bloating, diarrhea, or general stomach discomfort
Saxenda, Enobosarm, VK2735, TERN-601, and ECC5004, among others GLP-1 agonists are a type of medication used primarily in the treatment of type 2 diabetes and sometimes for weight management
Livadas S, Androulakis I, Angelopoulos N, Lytras A, Papagiannopoulos F, Kassi G
Baad, V
For instance, GIP and glucagon receptor activation assist in accelerating energy expenditure and can alter lipid metabolism
And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management